Baxter
BAX
#1106
Rank
A$26.43 B
Marketcap
$51.82
Share price
-1.14%
Change (1 day)
-2.16%
Change (1 year)

Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.

Baxter (BAX) - P/B ratio

P/B ratio as of November 2024 : 2.24

According to Baxter's latest financial reports the company has a price-to-book ratio of 1.15085.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Baxter - P/B ratio (from 2001 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-312.32-46.86%
2022-12-314.36-7.5%
2021-12-314.710.32%
2020-12-314.70-12.19%
2019-12-315.3524.62%
2018-12-314.2911.11%
2017-12-313.8632.64%
2016-12-312.9123.59%
2015-12-312.36-51.64%
2014-12-314.879.51%
2013-12-314.45-14.7%
2012-12-315.2227.7%
2011-12-314.09-5.54%
2010-12-314.33-8.99%
2009-12-314.75-10.92%
2008-12-315.340.2%
2007-12-315.3310.68%
2006-12-314.81-12.09%
2005-12-315.47-5%
2004-12-315.760.6%
2003-12-315.730.26%
2002-12-315.71

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
-9.12-507.48%๐Ÿ‡บ๐Ÿ‡ธ USA
7.32 227.09%๐Ÿ‡บ๐Ÿ‡ธ USA
6.24 178.66%๐Ÿ‡บ๐Ÿ‡ธ USA
2.58 15.40%๐Ÿ‡บ๐Ÿ‡ธ USA
16.8 648.18%๐Ÿ‡บ๐Ÿ‡ธ USA
4.21 88.14%๐Ÿ‡บ๐Ÿ‡ธ USA
1.14-49.09%๐Ÿ‡บ๐Ÿ‡ธ USA
2.35 5.02%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
2.13-4.71%๐Ÿ‡บ๐Ÿ‡ธ USA